These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3281396)

  • 1. [Current problems of blood group incompatibility in pregnancy].
    Wilken H
    Zentralbl Gynakol; 1988; 110(1):1-11. PubMed ID: 3281396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of hemolytic disease in newborn infants using anti-D immunoglobulin G].
    Mikulandra F; Perisa M; Merlak I; Kimer M; Glavadanović N
    Zentralbl Gynakol; 1989; 111(7):444-52. PubMed ID: 2786664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Errors in the prevention of Rh incompatibility].
    Dmoch E
    Acta Haematol Pol; 1988; 19(1-2):59-61. PubMed ID: 3149111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rhesus incompatibility and anti-D prevention in the Düsseldorf region (a ten-year survey) (author's transl)].
    Göbel U; Haering M; Fertmann J; Voss HV; Petrich C
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2010-3. PubMed ID: 808407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
    Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract]   [Full Text] [Related]  

  • 10. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 12. [Haemolytic disease of the new-born by blood-factor incompatibility other than Rh(d) and ABO (author's transl)].
    Schellong G; Sandmann G; Fischer K; Poschmann A
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1591-7. PubMed ID: 824115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inoculation of animals with anti-D immunoglobulin used for prophylaxis of hemolytic disease of the newborn. I. Titers of immune antiglobulin antibodies in the blood serum of rabbits inoculated with human anti-D immunoglobulin used in serologic incompatibility in the Rh system.
    Skorczyński M; Polak S; Marzec Z; Styblińska M
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):151-6. PubMed ID: 4192695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rhesus prevention and course following amniocentesis in early pregnancy].
    Herrmann U; Sidiropoulos D
    Gynakol Rundsch; 1983; 23(3):153-9. PubMed ID: 6605902
    [No Abstract]   [Full Text] [Related]  

  • 16. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn caused by Rh incompatibility from the recent neonatologic viewpoint. I. Development of morbidity in the regions of Erfurt and Suhl following general induction of preventive anti-D therapy].
    Menzel K; Kobelt L; Zimmermann U; Töpke B
    Kinderarztl Prax; 1979 May; 47(5):242-50. PubMed ID: 314017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.